Document Type
Article
Publication Date
11-30-2023
Original Citation
Liu W,
Wang Y,
Ulivi P,
Tavolari S,
Rizvi S,
Capobianco E,
Navarro A,
Zhang Y.
A signature of five 7-methylguanosine-related genes is a prognostic marker for lung squamous cell carcinoma. J Thorac Dis. 2023;15(11):6265-78
JAX Source
J Thorac Dis. 2023;15(11):6265-78
ISSN
2072-1439
PMID
38090319
DOI
https://doi.org/10.21037/jtd-23-1504
Grant
This study was supported in part by a grant from the Zhejiang Provincial Traditional Chinese Medicine Foundation (No. 2019ZA020).
Abstract
Background: N7-methylguanosine (m7G) is an important posttranscriptional modification affecting mRNA and tRNA functions and stability. The genes regulating the m7G process have been previously found involved in the carcinogenesis process. We aimed to analyze the role of m7G-related genes as potential prognostic markers for lung squamous cell carcinoma (LSCC).
Methods: Twenty-nine m7G-related genes were selected for the analysis in the LSCC cohort of the Cancer Genome Atlas (TCGA). Univariate, multivariate, and Kaplan-Meier analyses were used to evaluate the predictive value of risk model developed with m7G signature for overall survival (OS). The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of differentially expressed genes (DEGs) were performed for high- and low-risk LSCC groups.
Results: We identified 17 differentially expressed m7G methylation-related genes in LSCC versus normal tissues. The expression of five m7G-related genes (EIF3D, LSM1, NCBP2, NUDT10, and NUDT11) was identified as an independent prognostic marker for OS in LSCC patients. A risk model with these five m7G-related genes predicted 2-, and 3-year survival rates of 0.623 and 0.626, respectively. The risk score significantly correlated with OS: LSCC patients with a higher risk score had shorter OS (P<0.01) and it was associated with lower immune response (P<0.01).
Conclusions: We developed a novel m7G-related gene signature that can be of great utility to predict the prognosis for patients with LSCC.
Keywords: Non-small cell lung cancer (NSCLC); N7-methylguanosine (m7G); The Cancer Genome Atlas (TCGA); prognosis; biomarker
Comments
This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non- commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license).